Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Consultants and Independent Financial Advisors	Employees	Preferred Stock	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Consultants and Independent Financial Advisors	Additional Paid-In Capital Employees	Accumulated Deficit	Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of adoption of ASC 606 (See Note 2)	$ 24,785								$ 24,774	$ 11
Beginning Balance	395,176			$ 2	$ 20	$ 520,135			(125,004)	23
Beginning Balance (in shares) at Dec. 31, 2017				17,012,075	198,583,941
Beginning Balance at Dec. 31, 2017	370,391			$ 2	$ 20	520,135			(149,778)	12
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)					89,301
Issuance of common stock under employee stock purchase plan	281					281
Exercise of stock options (in shares)					1,507,080
Exercise of stock options, net of shares tendered in payment of exercise price	2,332					2,332
Stock-based compensation		$ 27	$ 3,035				$ 27	$ 3,035
Issuance of restricted stock (in shares)					2,115,000
Issuance of restricted stock	0
Repurchase and retirement of common stock (in shares)					(1,024,288)
Repurchase and retirement of common stock	(3,428)					(3,428)
Preferred stock issued, net of underwriting discount and expense	(89)					(89)
Preferred stock dividends declared and paid	(17,016)					(17,016)
Common stock dividends declared and paid	(3,929)					(3,929)
Net income	14,774								14,765	9
Ending Balance (in shares) at Jun. 30, 2018				17,012,075.000	201,271,034.000
Ending Balance at Jun. 30, 2018	391,163			$ 2	$ 20	501,348			(110,239)	32
Beginning Balance (in shares) at Mar. 31, 2018				17,012,075	200,517,787
Beginning Balance at Mar. 31, 2018	390,914			$ 2	$ 20	510,409			(119,541)	24
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)					29,357
Issuance of common stock under employee stock purchase plan	95					95
Exercise of stock options (in shares)					953,481
Exercise of stock options, net of shares tendered in payment of exercise price	1,504					1,504
Stock-based compensation		20	1,548				20	1,548
Issuance of restricted stock (in shares)					260,000
Issuance of restricted stock	0
Repurchase and retirement of common stock (in shares)					(489,591)
Repurchase and retirement of common stock	(1,699)					(1,699)
Preferred stock issued, net of underwriting discount and expense	(52)					(52)
Preferred stock dividends declared and paid	(8,508)					(8,508)
Common stock dividends declared and paid	(1,969)					(1,969)
Net income	9,310								9,302	8
Ending Balance (in shares) at Jun. 30, 2018				17,012,075.000	201,271,034.000
Ending Balance at Jun. 30, 2018	391,163			$ 2	$ 20	501,348			(110,239)	32
Beginning Balance (in shares) at Dec. 31, 2018				17,012,075	146,535,796
Beginning Balance at Dec. 31, 2018	253,177			$ 2	$ 14	344,356			(91,246)	51
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)					86,638
Issuance of common stock under employee stock purchase plan	250					250
Exercise of stock options (in shares)					2,205,077
Exercise of stock options, net of shares tendered in payment of exercise price	1,154				$ 0	1,154
Stock-based compensation		15	2,923				15	2,923
Issuance of restricted stock (in shares)					2,785,000
Issuance of restricted stock	$ 1				$ 1
Unvested restricted stock forfeitures (in shares)	(82,500.0)				(82,500)
Repurchase and retirement of common stock (in shares)					(3,028,880)
Repurchase and retirement of common stock	$ (10,347)					(10,347)
Preferred stock issued, net of underwriting discount and expense (in shares)				389,207
Preferred stock issued, net of underwriting discount and expense	9,449					9,449
Preferred stock dividends declared and paid	(17,285)					(17,285)
Common stock dividends declared and paid	(3,587)					(3,587)
Net income	10,940								10,919	21
Ending Balance (in shares) at Jun. 30, 2019				17,401,282.000	148,501,131.000
Ending Balance at Jun. 30, 2019	246,690			$ 2	$ 15	326,928			(80,327)	72
Beginning Balance (in shares) at Mar. 31, 2019				17,299,305	148,746,413
Beginning Balance at Mar. 31, 2019	254,022			$ 2	$ 15	341,768			(87,815)	52
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)					29,534
Issuance of common stock under employee stock purchase plan	96					96
Exercise of stock options (in shares)					2,034,860
Exercise of stock options, net of shares tendered in payment of exercise price	869					869
Stock-based compensation		$ 4	$ 1,440				$ 4	$ 1,440
Issuance of restricted stock (in shares)					460,000
Issuance of restricted stock	$ 0
Unvested restricted stock forfeitures (in shares)	(82,500)				(82,500)
Repurchase and retirement of common stock (in shares)					(2,687,176)
Repurchase and retirement of common stock	$ (9,295)					(9,295)
Preferred stock issued, net of underwriting discount and expense (in shares)				101,977
Preferred stock issued, net of underwriting discount and expense	2,534					2,534
Preferred stock dividends declared and paid	(8,695)					(8,695)
Common stock dividends declared and paid	(1,793)					(1,793)
Net income	7,508								7,488	20
Ending Balance (in shares) at Jun. 30, 2019				17,401,282.000	148,501,131.000
Ending Balance at Jun. 30, 2019	$ 246,690			$ 2	$ 15	$ 326,928			$ (80,327)	$ 72